| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2df384e38c54aa0bbff49095e7dedcfd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-101 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-865 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
| filingDate |
2021-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c46796a0c82565748b5194669d2f729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_924f9345747ff77e18a434a0664038f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21377f4c8ac3fb9fb1b7cd00fb9c073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963c3a9a050d5e156e804bca40146fdf |
| publicationDate |
2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113322271-A |
| titleOfInvention |
A subunit vaccine for COVID-19 based on a yeast surface display system |
| abstract |
The invention discloses a COVID-19 subunit vaccine based on a yeast surface display system, which belongs to the field of antiviral vaccines. The vaccine of the present invention is a novel vaccine obtained by displaying the surface antigen RBD of the novel coronavirus on the surface of the yeast by using a yeast surface display system to fuse and express the novel coronavirus antigen gene RBD gene and the lectin receptor Aga2 subunit. The vaccine of the invention is safe, effective, quick to prepare, convenient to use, and has good application prospects in the prevention and control of COVID-19 epidemic. |
| priorityDate |
2020-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |